Sclerostin Concentration and Bone Biomarker Trends in Patients with Spinal Cord Injury: A Prospective Study

Patients with spinal cord injury (SCI) experience a high osteoporosis incidence, which increases fracture risk. Recently, a sclerostin antibody was introduced as a target biomarker to treat osteoporosis. We aimed to determine the serum concentration of sclerostin and factors affecting its concentrat...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jong Ho, Cho, Jang Hyuk, Lee, Dong Gyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9222769/
https://www.ncbi.nlm.nih.gov/pubmed/35742035
http://dx.doi.org/10.3390/healthcare10060983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9222769/
https://www.ncbi.nlm.nih.gov/pubmed/35742035
http://dx.doi.org/10.3390/healthcare10060983

Ejemplares similares